Harry L. Leider - 28 Jun 2023 Form 4/A Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Role
Chief Executive Officer, Director
Signature
/s/ Harry L. Leider
Issuer symbol
ZEOX
Transactions as of
28 Jun 2023
Net transactions value
+$10,440
Form type
4/A
Filing time
21 Dec 2023, 16:01:40 UTC
Date Of Original Report
30 Jun 2023
Previous filing
09 Jun 2023
Next filing
20 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Purchase $5,440 +549,450 $0.009900 549,450 28 Jun 2023 See footnote F1
transaction OCEL Common Stock Purchase $5,000 +500,000 +91% $0.0100 1,049,450 29 Jun 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023.